A follow-up report on a new method of segmental resection for small-sized early lung cancer

Lung Cancer

Volumn 63, Issue 1, 2009, Pages 58-62

  Bando, Toru ^a   Miyahara, Ryo ^a   Sakai, Hiroaki ^a   Shoji, Tsuyoshi ^a   Sonobe, Makoto ^a   Sato, Kiyoshi ^a   Fujinaga, Takuji ^a   Chen, Fengshi ^a   Okubo, Kenichi ^a   Hirata, Toshiki ^a   Wada, Hiromi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Early lung cancer; Locoregional recurrences; Lung cancer surgery; Outcomes; Segmentectomy; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT INDICATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 57649096599     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.04.012     Document Type: Article

References (17)

1. Warren W.H., and Faber L.P. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 107 (1994) 1087-1094
2. Landreneau R.J., Sugarbaker D.J., Mack M.J., Hazelrigg S.R., Luketich J.D., Fetterman L., et al. Wedge resection versus lobectomy for stage I (T1N0M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg 113 (1997) 691-700
3. Jones D.R., Stiles B.M., Denlinger C.E., Antippa P., and Daniel T.M. Pulmonary segmentectomy: results and complications. Ann Thorac Surg 76 (2003) 343-349
4. Martin-Ucar A.E., Nakas A., Pilling J.E., West K.J., and Waller D.A. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 27 (2005) 675-679
5. Ginsberg R.J., and Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60 (1995) 615-622
6. Bando T., Yanagihara K., Ohtake Y., Miyahara R., Tanaka F., Hasegawa S., et al. A new method of segmental resection for primary lung cancer: intermediate results. Eur J Cardiothorac Surg 21 (2002) 894-899
7. Yoshikawa K., Tsubota N., Kodama K., Ayabe H., Taki T., and Mori T. Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg 73 (2002) 1055-1059
8. Koike T., Yamato Y., Yoshiya K., Shimoyama T., and Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 125 (2003) 924-928
9. Okada M., Koike T., Higashiyama M., Yamato Y., Kodama K., and Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 132 (2006) 769-775
10. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
11. Miller D.L., Rowland C.M., Deschamps C., Allen M.S., Trastek V.F., and Pairolero P.C. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 73 (2002) 1545-1551
12. Inoue M., Minami M., Shiono H., Sawabata N., Ideguchi K., and Okumura M. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg 131 (2006) 988-993
13. Kodama K., Doi O., Higashiyama M., and Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg 114 (1997) 347-353
14. Matsuguma H., Yokoi K., Anraku M., Kondo T., Kamiyama Y., Mori K., et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg 124 (2002) 278-284
15. Okada M., Nishio W., Sakamoto T., Uchino K., Yuki T., Nakagawa A., et al. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1000 consecutive resections for clinical stage I disease. Ann Thorac Surg 78 (2004) 216-221
16. Pujol J.L., Molinier O., Ebert W., Daures J.P., Barlesi F., Buccheri G., et al. CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients. Br J Cancer 90 (2004) 2097-2105
17. Takeuchi S., Nonaka M., Kadokura M., and Takaba T. Prognostic significance of serum squamous cell carcinoma antigen in surgically treated lung cancer. Ann Thorac Cardiovasc Surg 9 (2003) 98-104